The University of Puerto Rico Medical Sciences Campus will receive $1.3 million under a three-year Project Grant award from the Defense Health Agency to support translational development of MBQ-167 as a targeted therapy for metastatic breast cancer. Through the Military Medical Research and Development program (CFDA 12.420), the award will fund applied and advanced biomedical research efforts aimed at transforming healthcare for service members and the general public. Specifically, the University will conduct research to investigate MBQ-167, a potential medical solution for the battlefield and beyond, as part of the program's mission to support innovative and impactful medical research.
Generated 1/7/24, 10:29 AM